34 units semaglutide Weaning Off GLP-1 Medications: A Sustainable Approach Semaglutide & Tirzepatide Dosing Guide:
Description
A one-year course of semaglutide partially reversed WR, suggesting a potential adjunctive role for GLP-1 agonists in selected patients
It regulates the secretion and sensitivity of insulin while suppressing glucagon secretion and decreasing postprandial glucose levels
It also slows gastric emptying, thereby helping patients control their food intake and body weight
Schematic illustration below was taken from He et al
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become essential medications in the management of type 2 diabetes mellitus and obesity due to their ability to improve glucose control and facilitate weight loss by enhancing insulin ...
